Explore more publications!

Potomac Health News Press Releases

Labels On
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
Info
Traws Pharma Reports Third Quarter 2025 Results and Business Highlights
Art gallery opens at new State Health Laboratories

Art gallery opens at new State Health Laboratories

MOH INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Molina Healthcare, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
Art gallery opens at new State Health Laboratories

Art gallery opens at new State Health Laboratories

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stride, Firefly, Six Flags, and Inspire Medical and Encourages Investors to Contact the Firm
FOWPAL Inspires Global Unity and Action at the Ambassador’s Peace Ball in Washington, D.C.
The Leader’s Floor Lookout: Week of November 17, 2025
High Dose Regimen of Nusinersen Receives Positive CHMP Opinion for the Treatment of Spinal Muscular Atrophy
Whitney Coleman, LICSW, LCSW-C Launches 'Reclaiming C.A.L.M.: A Practical Guide to Managing Anxiety'
4DMT Appoints Kristian Humer as Chief Financial Officer
Emmy Award-Winning Anchor Linsey Davis and Legendary DJ D-Nice to host, emcee 19th Biennial Uncommon Height Honors Gala
ITM Receives U.S. FDA Fast Track Designation for ITM-94 as a Diagnostic Agent for Clear Cell Renal Cell Carcinoma
SCHMID's update on positive developments in the market leading to a positive outlook for 2026, while 2025 and 2024 remain transition years below expectations
HHS Advances Women’s Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy
Addiction and Recovery Psychologist Harris Stratyner, Ph.D Discusses  Gambling Addiction and Sports Betting
Robbins Geller Rudman & Dowd LLP Announces that Telix Pharmaceuticals Ltd. (TLX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
LFTD Partners Inc. Reports Q3 2025 Basic EPS of $0.04
Tonix Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operational Highlights
New Academy of Nutrition and Dietetics Position Paper Reinforces the Power of Medical Nutrition Therapy in Chronic Disease Care
B&C to Present Lexology Masterclass 'PFAS in Consumer Products' Webinar on December 2 - DELETED

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions